Cholesterol Management Update- Pharmacist

  Price  

  Credits  1.5

This product is currently out of stock and unavailable.


Format
Several approaches to cholesterol management have traditionally been used, including "treat-to-target" and "lower is better." In 2001, the National Cholesterol Education Program (NCEP) issued a guideline on cholesterol management that was most recently updated in 2004. The guideline set specific LDL targets for treatment in different risk groups. In November of 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) published an updated cholesterol guideline to help providers reduce the overall risk for atherosclerotic cardiovascular disease (ASCVD). As in the previous guideline, lifestyle measures such as a heart-healthy diet, regular exercise, avoiding tobacco products, and maintaining a healthy weight remain the foundation for risk reduction (see the Patient Connection). However, the 2013 recommendations for drug treatment (specifically, statin use) represent a paradigm shift. The 2013 guideline features the elimination of LDL and non-HDL treatment targets; the identification of 4 statin benefit groups with corresponding recommendations for the intensity of statin treatment; the introduction of a new cardiovascular (CV) risk assessment calculator, to estimate 10-year ASCVD risk; and safety recommendations, including management of statin side effects. The new guideline has been the subject of intense controversy. This issue of The Rx Consultant presents the guideline’s background, its key recommendations for treatment and for safety monitoring, and a discussion of the controversy it caused. You'll also find additional statin information (updated since our 2006 issue) including key differences among agents.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0428-0000-14-004-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.